RCM
ENTF

Radcliffe Capital Management’s Enterprise 4.0 Technology Acquisition Corp. Class A Ordinary Shares ENTF Stock Holding History

Radcliffe Capital Management’s Portfolio ENTF Stock Details ENTF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-461,953
Closed -$4.92M – 571
2023
Q2 		$4.92M Buy
461,953
+8,885
+2% +$93.6K 0.42% 66
2023
Q1 		$4.73M Buy
453,068
+22,448
+5% +$233K 0.3% 104
2022
Q4 		$4.43M Buy
430,620
+7,279
+2% +$74.1K 0.14% 227
2022
Q3 		$4.27M Buy
423,341
+5,590
+1% +$56.1K 0.1% 332
2022
Q2 		$4.17M Buy
417,751
+11,651
+3% +$116K 0.1% 346
2022
Q1 		$4.04M Buy
406,100
+6,100
+2% +$60.3K 0.09% 332
2021
Q4 		$3.96M Buy
+400,000
New +$3.95M 0.1% 279

Radcliffe Capital Management's ENTF Position: Q3 2023 in Review

Radcliffe Capital Management sold out of Enterprise 4.0 Technology Acquisition Corp. Class A Ordinary Shares (ENTF) in Q3 2023, closing a stake of 461,953 shares — an estimated $4.92M sold.

Radcliffe Capital Management first reported a position in ENTF in Q4 2021 and held it in 7 quarters. The position peaked at $4.92M in Q2 2023. 0 funds tracked by Wall St. Rank hold ENTF as of Q3 2023.

  • Radcliffe Capital Management reported no remaining Enterprise 4.0 Technology Acquisition Corp. Class A Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 461,953 Enterprise 4.0 Technology Acquisition Corp. Class A Ordinary Shares shares in Q3 2023, an estimated $4.92M.
  • Radcliffe Capital Management first reported a position in Enterprise 4.0 Technology Acquisition Corp. Class A Ordinary Shares in Q4 2021 and held it in 7 quarters.
  • Radcliffe Capital Management's Enterprise 4.0 Technology Acquisition Corp. Class A Ordinary Shares position peaked at $4.92M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Enterprise 4.0 Technology Acquisition Corp. Class A Ordinary Shares as of Q3 2023.

Based on Radcliffe Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.